Skip to content
10-Q

Quarterly Report

XBIOTECH INC. XBIT

0001171843-25-007233

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 12, 2025 30.49M sh
Capex Q3 2025 · Sep 30, 2025 $255K
Capex Q3 2025 · Sep 30, 2024 $1.22M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$16.97M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$24.42M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $147.37M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $172.68M
Stockholders Equity Q3 2025 · Sep 30, 2025 $167.08M
Stockholders Equity Q3 2025 · Jun 30, 2025 $173.06M
Stockholders Equity Q3 2025 · Dec 31, 2024 $182.27M
Stockholders Equity Q3 2025 · Sep 30, 2024 $192.12M
Stockholders Equity Q3 2025 · Jun 30, 2024 $196.7M
Stockholders Equity Q3 2025 · Dec 31, 2023 $218.85M
Current Liabilities Q3 2025 · Sep 30, 2025 $3.57M
Current Liabilities Q3 2025 · Dec 31, 2024 $15.11M
Total Liabilities Q3 2025 · Sep 30, 2025 $5.34M
Total Liabilities Q3 2025 · Dec 31, 2024 $16.83M
Current Assets Q3 2025 · Sep 30, 2025 $148.95M
Current Assets Q3 2025 · Dec 31, 2024 $174.57M
Total Assets Q3 2025 · Sep 30, 2025 $172.42M
Total Assets Q3 2025 · Dec 31, 2024 $199.09M
Eps Basic Q3 2025 · Sep 30, 2025 −$0.20
Eps Basic Q3 2025 · Sep 30, 2025 −$0.61
Eps Basic Q3 2025 · Sep 30, 2024 −$0.16
Eps Basic Q3 2025 · Sep 30, 2024 −$0.92
Sga Expense Q3 2025 · Sep 30, 2025 $967K
Sga Expense Q3 2025 · Sep 30, 2025 $3.9M
Sga Expense Q3 2025 · Sep 30, 2024 $777K
Sga Expense Q3 2025 · Sep 30, 2024 $3.79M
Rd Expense Q3 2025 · Sep 30, 2025 $5.08M
Rd Expense Q3 2025 · Sep 30, 2025 $22.03M
Rd Expense Q3 2025 · Sep 30, 2024 $7.13M
Rd Expense Q3 2025 · Sep 30, 2024 $29.94M
Net Income Q3 2025 · Sep 30, 2025 −$6.01M
Net Income Q3 2025 · Sep 30, 2025 −$18.65M
Net Income Q3 2025 · Sep 30, 2024 −$5.02M
Net Income Q3 2025 · Sep 30, 2024 −$28.02M
Operating Income Q3 2025 · Sep 30, 2025 −$6.05M
Operating Income Q3 2025 · Sep 30, 2025 −$25.93M
Operating Income Q3 2025 · Sep 30, 2024 −$7.9M
Operating Income Q3 2025 · Sep 30, 2024 −$33.72M